Kodiak Sciences Inc. KOD
- KSI-501 — Wet Age-Related Macular Degeneration Phase 3
- KSI-101 — Macular Edema Secondary to Inflammation Phase 3
- KSI-102 Preclinical
- KSI-103 Preclinical
- KSI-501 — Diabetic Macular Edema Phase 3
Companies with an active program directed at IL-6.